Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer
出版年份 2022 全文链接
标题
Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer
作者
关键词
-
出版物
PHARMACOLOGY & THERAPEUTICS
Volume 239, Issue -, Pages 108296
出版商
Elsevier BV
发表日期
2022-10-05
DOI
10.1016/j.pharmthera.2022.108296
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion
- (2022) Emanuela Guerra et al. ONCOGENE
- TROP-2, Nectin-4, GPNMB, and B7-H3 Are Potentially Therapeutic Targets for Anaplastic Thyroid Carcinoma
- (2022) Soji Toda et al. Cancers
- TROP-2 and 5hmC expression in follicular-patterned thyroid neoplasm emphasizing tiny well-formed papillae
- (2022) Jae Yeon Seok et al. Annals of Diagnostic Pathology
- Abstract GS1-05: Datopotamab deruxtecan in advanced/metastatic HER2- breast cancer: Results from the phase 1 TROPION-PanTumor01 study
- (2022) Ian Krop et al. CANCER RESEARCH
- TROP2: a potential marker in diagnosis of thyroid neoplasms
- (2022) Zübeyir Turan et al. IRISH JOURNAL OF MEDICAL SCIENCE
- Primary results from TROPiCS-02: A randomized phase 3 study of sacituzumab govitecan (SG) versus treatment of physician’s choice (TPC) in patients (Pts) with hormone receptor–positive/HER2-negative (HR+/HER2-) advanced breast cancer.
- (2022) Hope S. Rugo et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 2 study of response-guided neoadjuvant sacituzumab govitecan (IMMU-132) in patients with localized triple-negative breast cancer: Results from the NeoSTAR trial.
- (2022) Laura Spring et al. JOURNAL OF CLINICAL ONCOLOGY
- Trop2 deal heats up antibody–drug conjugate space in cancer
- (2021) Catherine Shaffer NATURE BIOTECHNOLOGY
- Trophoblast cell surface antigen 2 expression predicts outcome in oral squamous cell carcinomas
- (2021) Mauricio Rocha Dourado et al. ORAL DISEASES
- TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors
- (2021) Scott T. Tagawa et al. JOURNAL OF CLINICAL ONCOLOGY
- Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
- (2021) Aditya Bardia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trop‐2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis
- (2021) Marco Trerotola et al. NEOPLASIA
- Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial
- (2021) A. Bardia et al. ANNALS OF ONCOLOGY
- ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer
- (2021) Weiyu Chen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Outcomes in patients (pts) aged ≥65 years in the phase 3 ASCENT study of sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC).
- (2021) Kevin Kalinsky et al. JOURNAL OF CLINICAL ONCOLOGY
- Datopotamab deruxtecan (Dato-DXd), a novel TROP2-directed antibody-drug conjugate, demonstrates potent antitumor activity by efficient drug delivery to tumor cells
- (2021) Daisuke Okajima et al. MOLECULAR CANCER THERAPEUTICS
- Engineering Complex Anisotropic Scaffolds beyond Simply Uniaxial Alignment for Tissue Engineering
- (2021) Jiyao Xing et al. ADVANCED FUNCTIONAL MATERIALS
- Impact of Spatially Heterogeneous Trop-2 Expression on Prognosis in Oral Squamous Cell Carcinoma
- (2021) Ramona Erber et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MA03.02 TROPION-PanTumor01: Updated Results From the NSCLC Cohort of the Phase 1 Study of Datopotamab Deruxtecan in Solid Tumors
- (2021) E. Garon et al. Journal of Thoracic Oncology
- Oncogene-mediated metabolic gene signature predicts breast cancer outcome
- (2021) Merve Aslan et al. npj Breast Cancer
- Structural insights into the cis and trans assembly of human trophoblast cell surface antigen 2
- (2021) Meng Sun et al. iScience
- Clinical impact of TROP2 in non‐small lung cancers and its correlation with abnormal p53 nuclear accumulation
- (2020) Remi Mito et al. PATHOLOGY INTERNATIONAL
- Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1
- (2020) En-Chi Hsu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan
- (2020) Burak Zeybek et al. Scientific Reports
- Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer
- (2020) Emanuele Perrone et al. Frontiers in Oncology
- Proteolytic cleavage of Trop2 at Arg87 is mediated by matriptase and regulated by Val194
- (2020) Pradnya R Kamble et al. FEBS LETTERS
- Trop2 inhibition of P16 expression and the cell cycle promotes intracellular calcium release in OSCC
- (2020) Lizhou Jia et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trial
- (2020) K. Kalinsky et al. ANNALS OF ONCOLOGY
- Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation
- (2020) Baoping Zhang et al. BMC CANCER
- Mechanistic Insights into Trop2 Clustering on Lung Cancer Cell Membranes Revealed by Super-resolution Imaging
- (2020) Yilin Fu et al. ACS Omega
- The role and molecular mechanism of Trop2 induced epithelial-mesenchymal transition through mediated β-catenin in gastric cancer
- (2019) Wei Zhao et al. Cancer Medicine
- Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
- (2019) Aditya Bardia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sacituzumab govitecan (IMMU-132) in patients with previously treated metastatic urothelial cancer (mUC): Results from a phase I/II study.
- (2019) Scott T. Tagawa et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Latest Research and Development into the Antibody–Drug Conjugate, [fam-] Trastuzumab Deruxtecan (DS-8201a), for HER2 Cancer Therapy
- (2019) Takashi Nakada et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Trophoblast cell surface antigen 2 (Trop-2) phosphorylation by protein kinase C α/δ (PKCα/δ) enhances cell motility
- (2019) Yugo Mori et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Novel HER3-Targeting Antibody-Drug Conjugate, U3-1402, Exhibits Potent Therapeutic Efficacy through the Delivery of Cytotoxic Payload by Efficient Internalization
- (2019) Yuuri Hashimoto et al. CLINICAL CANCER RESEARCH
- Photoimmunotherapy targeting biliary‐pancreatic cancer with humanized anti‐TROP2 antibody
- (2019) Takashi Nishimura et al. Cancer Medicine
- Variation of Trop2 on non-small-cell lung cancer and normal cell membranes revealed by super-resolution fluorescence imaging
- (2019) Yilin Fu et al. TALANTA
- TROP2 methylation and expression in tamoxifen-resistant breast cancer
- (2018) Stephanie M. Zimmers et al. Cancer Cell International
- Trop-2 plasticity is controlled by epithelial-to-mesenchymal transition
- (2018) Ján Remšík et al. CARCINOGENESIS
- The diagnostic value of TROP-2, SLP-2 and CD56 expression in papillary thyroid carcinoma
- (2018) Xueyang Yang et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- A phase 1, dose-escalation study of PF-06664178, an anti-Trop-2/Aur0101 antibody-drug conjugate in patients with advanced or metastatic solid tumors
- (2018) Gentry T. King et al. INVESTIGATIONAL NEW DRUGS
- Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
- (2018) Rahul Aggarwal et al. JOURNAL OF CLINICAL ONCOLOGY
- The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target
- (2018) David M. Goldenberg et al. Oncotarget
- High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma
- (2018) Genxiong Tang et al. PATHOLOGY RESEARCH AND PRACTICE
- TROP-2 exhibits tumor suppressive functions in cervical cancer by dual inhibition of IGF-1R and ALK signaling
- (2018) Sarah T.K. Sin et al. GYNECOLOGIC ONCOLOGY
- Matriptase-mediated cleavage of EpCAM destabilizes claudins and dysregulates intestinal epithelial homeostasis
- (2017) Chuan-Jin Wu et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor-associated calcium signal transducer 2 regulates neovascularization of non-small-cell lung cancer via activating ERK1/2 signaling pathway
- (2017) Xiaobin Guo et al. TUMOR BIOLOGY
- Overexpression of TROP2 promotes proliferation and invasion of ovarian cancer cells
- (2017) Bin Wu et al. Experimental and Therapeutic Medicine
- TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT
- (2017) Xinxing Li et al. Oncotarget
- Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes
- (2017) Kentaro Inamura et al. Oncotarget
- The Potential Diagnostic Utility of TROP-2 in Thyroid Neoplasms
- (2017) Haiyan Liu et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- TROP2 overexpression promotes proliferation and invasion of lung adenocarcinoma cells
- (2016) Zanhua Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- v-Src Oncogene Induces Trop2 Proteolytic Activation via Cyclin D1
- (2016) Xiaoming Ju et al. CANCER RESEARCH
- Trop-2 Induces Tumor Growth Through AKT and Determines Sensitivity to AKT Inhibitors
- (2016) Emanuela Guerra et al. CLINICAL CANCER RESEARCH
- DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1
- (2016) Y. Ogitani et al. CLINICAL CANCER RESEARCH
- Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma
- (2016) Ning Xu et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- TROP-2 immunohistochemistry: a highly accurate method in the differential diagnosis of papillary thyroid carcinoma
- (2016) Andrey Bychkov et al. PATHOLOGY
- High expression of TROP2 characterizes different cell subpopulations in androgen-sensitive and androgen-independent prostate cancer cells
- (2016) Jinhan Xie et al. Oncotarget
- Pr1E11, a novel anti-TROP-2 antibody isolated by adenovirus-based antibody screening, recognizes a unique epitope
- (2015) Masahiro Ikeda et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Differential regulation of TROP2 release by PKC isoforms through vesicles and ADAM17
- (2015) Tim M. Wanger et al. CELLULAR SIGNALLING
- First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors
- (2015) A. N. Starodub et al. CLINICAL CANCER RESEARCH
- Trop2: From development to disease
- (2015) Annie R.A. McDougall et al. DEVELOPMENTAL DYNAMICS
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Trop2 is overexpressed in gastric cancer and predicts poor prognosis
- (2015) Wei Zhao et al. Oncotarget
- Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts
- (2015) Marco Trerotola et al. Oncotarget
- The cytosolic tail of the tumor marker protein Trop2 - a structural switch triggered by phosphorylation
- (2015) Miha Pavšič et al. Scientific Reports
- SIRT3 & SIRT7: Potential Novel Biomarkers for Determining Outcome in Pancreatic Cancer Patients
- (2015) Liane M. McGlynn et al. PLoS One
- Loss of Trop2 causes ErbB3 activation through a neuregulin-1-dependent mechanism in the mesenchymal subtype of HNSCC
- (2015) Kaihua Zhang et al. Oncotarget
- Pretargeted Radioimmunotherapy of Prostate Cancer with an Anti-TROP-2×Anti-HSG Bispecific Antibody and a 177Lu-Labeled Peptide
- (2014) Catharina M. van Rij et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Pretargeted Dual-Modality Immuno-SPECT and Near-Infrared Fluorescence Imaging for Image-Guided Surgery of Prostate Cancer
- (2014) S. Lutje et al. CANCER RESEARCH
- Transcriptional Roles of PARP1 in Cancer
- (2014) Matthew J. Schiewer et al. MOLECULAR CANCER RESEARCH
- Redirected T-Cell Killing of Solid Cancers Targeted with an Anti-CD3/Trop-2-Bispecific Antibody Is Enhanced in Combination with Interferon-
- (2014) E. A. Rossi et al. MOLECULAR CANCER THERAPEUTICS
- Pretargeted ImmunoPET of Prostate Cancer with an Anti-TROP-2 x Anti-HSG Bispecific Antibody in Mice with PC3 Xenografts
- (2014) Catharina M. van Rij et al. MOLECULAR IMAGING AND BIOLOGY
- Trop-2 Is a Determinant of Breast Cancer Survival
- (2014) Federico Ambrogi et al. PLoS One
- Prognostic value of TROP2 expression in patients with gallbladder cancer
- (2014) Min-Bin Chen et al. TUMOR BIOLOGY
- Crystal structure and its bearing towards an understanding of key biological functions of EpCAM
- (2014) Miha Pavšič et al. Nature Communications
- EpCAM proteolysis: new fragments with distinct functions?
- (2013) Ulrike Schnell et al. BIOSCIENCE REPORTS
- Trop-2 Promotes Prostate Cancer Metastasis By Modulating 1 Integrin Functions
- (2013) M. Trerotola et al. CANCER RESEARCH
- Pretargeted immuno-PET and radioimmunotherapy of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody
- (2013) Catharina M. van Rij et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- A novel human Fab antibody for Trop2 inhibits breast cancer growthin vitroandin vivo
- (2013) Hong Lin et al. INTERNATIONAL JOURNAL OF CANCER
- Biochemical and preliminary X-ray characterization of the tumor-associated calcium signal transducer 2 (Trop2) ectodomain
- (2013) Tilen Vidmar et al. PROTEIN EXPRESSION AND PURIFICATION
- Expression and clinical significance of the Trop-2 gene in advanced non-small cell lung carcinoma
- (2013) AIGUI JIANG et al. Oncology Letters
- TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma
- (2012) Jau-Chen Lin et al. EMBO Molecular Medicine
- Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via -catenin signaling
- (2012) T. Stoyanova et al. GENES & DEVELOPMENT
- Trop-2 inhibits prostate cancer cell adhesion to fibronectin through the β1 integrin-RACK1 axis
- (2012) Marco Trerotola et al. JOURNAL OF CELLULAR PHYSIOLOGY
- A New Tri-Fab Bispecific Antibody for Pretargeting Trop-2-Expressing Epithelial Cancers
- (2012) R. M. Sharkey et al. JOURNAL OF NUCLEAR MEDICINE
- Upregulation of Trop-2 quantitatively stimulates human cancer growth
- (2012) M Trerotola et al. ONCOGENE
- Significance of EpCAM and TROP2 expression in non-small cell lung cancer
- (2012) Min Pak et al. World Journal of Surgical Oncology
- Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody
- (2011) Joyce Varughese et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- The oncogene Trop2 regulates fetal lung cell proliferation
- (2011) Annie R. A. McDougall et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Humanized Anti-Trop-2 IgG-SN-38 Conjugate for Effective Treatment of Diverse Epithelial Cancers: Preclinical Studies in Human Cancer Xenograft Models and Monkeys
- (2011) T. M. Cardillo et al. CLINICAL CANCER RESEARCH
- Loss of nuclear expression of Krüppel-like factor 4 is associated with poor prognosis in patients with oral cancer
- (2011) Chih-Jung Chen et al. HUMAN PATHOLOGY
- Expression of Trop2 Cell Surface Glycoprotein in Normal and Tumor Tissues
- (2011) Lara P. Stepan et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- TROP2 Expressed in the Trunk of the Ureteric Duct Regulates Branching Morphogenesis during Kidney Development
- (2011) Yuko Tsukahara et al. PLoS One
- Tumor-Associated Calcium Signal Transducer 2 Is Required for the Proper Subcellular Localization of Claudin 1 and 7
- (2010) Mina Nakatsukasa et al. AMERICAN JOURNAL OF PATHOLOGY
- Global Reactivation of Epigenetically Silenced Genes in Prostate Cancer
- (2010) I. Ibragimova et al. Cancer Prevention Research
- Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients
- (2010) Eliana Bignotti et al. EUROPEAN JOURNAL OF CANCER
- Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway
- (2010) Rafael Cubas et al. Molecular Cancer
- Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer
- (2009) Y. J. Fang et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- High expression of TROP2 correlates with poor prognosis in pancreatic cancer
- (2008) D Fong et al. BRITISH JOURNAL OF CANCER
- A Bicistronic CYCLIN D1-TROP2 mRNA Chimera Demonstrates a Novel Oncogenic Mechanism in Human Cancer
- (2008) E. Guerra et al. CANCER RESEARCH
- TROP2 expression as prognostic marker for gastric carcinoma
- (2008) G Muhlmann et al. JOURNAL OF CLINICAL PATHOLOGY
- Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers
- (2008) J. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics
- (2008) A. S. Goldstein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started